The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting
News
2026.02.02
*Information* International Seminar will be held on Tuesday, March 31
News
2026.01.30
*Announcement* External Lecturer Seminar on Monday, March 2
News
2026.01.26
*Article Published*Article Published in JVM NEWS
News
2026.01.23
Article published Article on PR TIMES
News
2026.01.19
*Announcement*Yamaguchi University Launches Crowdfunding Campaign to Develop Rapid Test Kit for “Cat Scratch Disease” (Public Lecture to be held on Jan 31)
News
2026.01.13
*Report* External Lecturer Seminar Held
News
2026.01.13
*Announcement*Our Faculty Members Ranked in the Top 2% of the World’s Most Influential Scientists
News
2026.01.05
*Article published* Article in the Nikkei Biotechnology & Business
Thesis
2026.02.07
CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunity
Thesis
2026.01.23
Acute changes in indices of cardiac filling and function induced by high-dose intravenous methylprednisolone pulse therapy: a single-center prospective study
Thesis
2026.01.23
Caninized PD-1 monoclonal antibody in oral malignant melanoma: efficacy and exploratory biomarker analysis
Thesis
2026.01.13
Development of a Smart Contact Lens for High-Sensitivity Wireless Intraocular Pressure Monitoring: Demonstration of Effectiveness in Glaucoma Evaluation
Thesis
2025.11.12
CXCL8 mediates macrophage migration in canine oral malignant melanoma
Thesis
2025.10.08
Anastomotic leakage prevention using dry-preserved fibroblast cell sheets in esophageal reconstruction
Thesis
2025.09.29
Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma
Thesis
2025.09.08
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease
The article could not be found.
Thesis
2026.02.07
CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunity
News
2026.02.02
*Information* International Seminar will be held on Tuesday, March 31
News
2026.01.30
*Announcement* External Lecturer Seminar on Monday, March 2
News
2026.01.26
*Article Published*Article Published in JVM NEWS
News
2026.01.23
Article published Article on PR TIMES
Thesis
2026.01.23
Caninized PD-1 monoclonal antibody in oral malignant melanoma: efficacy and exploratory biomarker analysis
Thesis
2026.01.23
Acute changes in indices of cardiac filling and function induced by high-dose intravenous methylprednisolone pulse therapy: a single-center prospective study
News
2026.01.19
*Announcement*Yamaguchi University Launches Crowdfunding Campaign to Develop Rapid Test Kit for “Cat Scratch Disease” (Public Lecture to be held on Jan 31)
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー
